8-K: Artiva Biotherapeutics, Inc. — Item 2.05 Cost Associated with Exit or Disposal Activities
Filed: 2026-10-27 AccNo: 0001193125-26-432806 Size: 178 KB Item 2.02: Results of Operations and Financial Condition Item 2.05: Cost Associated with Exit or